Otro sistema para preservar el cabello en pacientes con quimio para cancer de mama.

FDA Gives Marketing Clearance For Scalp Cooling System For Reducing Hair Loss In Breast Cancer Patients Undergoing Chemotherapy.

Medscape (4/19, Mulcahy) reports that the FDA "has given marketing clearance for the Paxman Scalp Cooling System for reducing hair loss in breast cancer patients undergoing chemotherapy." This "device becomes the second hair loss prevention system okayed by the FDA following the 2015 clearance of the DigniCap Cooling System."

        Healio (4/19) reports that the new "device is intended to reduce the amount of chemotherapy that reaches the hair follicles, reduce drug diffusion through the cell membrane, decrease cell division, reduce active transport mechanisms and generally reduce metabolic activity."

Benjamin Hidalgo-Matlock

Skin Care Physicians of Costa Rica

4000-1054

2208-8206

Please excuse the shortness of this message, as it has been sent from a mobile device.